YOLFTbeta
30

Ningbo MedicalSystem Biotechnology Co Ltd

300439 · SHE · Healthcare / Diagnostics & Research

9.43CNY-0.47 (-4.75%)

Price History

Full chart

Market Stats

Previous Close9.90
Open9.85
Day Range9.31 – 9.87
52-Week Range7.83 – 11.07
Volume7.99M
Market Cap3.93B
P/E (TTM)60.29
Forward P/E0.00
EPS0.17
Dividend Yield0.32%
Beta0.32
50-Day Avg9.27
200-Day Avg9.58

About

Medicalsystem Biotechnology Co., Ltd. researches, develops, produces, and sells in vitro diagnostic products in China. It is also involved in the provision of third-party medical diagnostic services. The company offers chemiluminescence, biochemistry, integrated combination, TLA system, hematology, point-of-care testing (POCT), mass spectrometry, and blood lipid subfraction analysis. It also provides healthcare services. Medicalsystem Biotechnology Co., Ltd. was formerly known as Ningbo Medicalsystem Biotechnology Co., Ltd. and changed its name to Biotechnology Co., Ltd. in January 2017. The company was founded in 2003 and is based in Ningbo, China.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Ji Hua Zou
  • Employees1.94K
  • HeadquartersNo. 1228, Jinda South Road, Ningbo, China, 315104, China
  • Websitehttps://www.nbmksw.com

Leadership

  • Mr. Ji Hua ZouGM & Non-Independent Director · b. 1979
  • Ms. Huiping XiongDeputy GM, CFO & Board Secretary · b. 1979
  • Mr. Min ShenDeputy General Manager · b. 1981
  • Mr. Liang FangDeputy General Manager · b. 1980
  • Ting WangHead of Accounting Department

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue192.52M327.74M432.06M597.85M683.14M1.06B2.58B3.14B3.13B2.30B2.25B2.49B1.89B1.74B1.54B
Growth (%)-+70.24%+31.83%+38.37%+14.27%+54.44%+144.93%+21.32%-0.05%-26.53%-2.19%+10.55%-24.23%-7.61%-11.67%
Cost of Revenue77.15M134.11M181.02M262.42M284.07M489.24M1.62B2.07B2.10B1.47B1.35B1.55B1.06B972.72M972.74M
Gross Profit115.37M193.63M251.05M335.43M399.07M565.82M967.93M1.07B1.03B830.24M903.98M937.49M825.44M769.70M566.42M
Gross Margin59.93%59.08%58.10%56.11%58.42%53.63%37.46%34.13%33.02%36.07%40.15%37.66%43.77%44.17%36.80%
Operating Expense49.22M83.93M122.85M170.65M222.92M355.81M622.28M728.40M1.56B657.33M684.28M708.84M546.33M502.17M505.02M
Operating Income66.15M109.70M128.19M164.78M176.15M210.01M345.65M341.71M-525.43M172.92M219.70M228.64M279.12M267.53M61.40M
Operating Margin34.36%33.47%29.67%27.56%25.79%19.90%13.38%10.90%-16.77%7.51%9.76%9.19%14.80%15.35%3.99%
EBITDA73.48M129.15M150.83M202.93M236.33M305.68M488.77M574.91M-282.19M575.71M421.52M409.06M459.35M474.58M221.45M
EBITDA Margin38.17%39.40%34.91%33.94%34.60%28.97%18.91%18.34%-9.01%25.01%18.72%16.43%24.36%27.24%14.39%
Net Income53.33M91.73M103.53M137.68M161.27M177.49M229.70M241.17M-559.91M299.48M179.49M198.53M256.55M258.00M63.20M
Net Income Margin27.70%27.99%23.96%23.03%23.61%16.82%8.89%7.69%-17.87%13.01%7.97%7.98%13.60%14.81%4.11%
R&D-13.30M17.50M24.19M39.93M57.86M92.57M109.64M128.26M135.48M150.68M171.78M149.80M146.47M127.20M
R&D as % of Total Revenue-4.06%4.05%4.05%5.85%5.48%3.58%3.50%4.09%5.89%6.69%6.90%7.94%8.41%8.26%
Interest Expense990.57K2.99M2.28M5.65M2.53M12.07M56.33M84.70M82.04M55.57M29.88M16.63M10.91M2.72M2.57M
Interest Expense % of Total Revenue0.51%0.91%0.53%0.95%0.37%1.14%2.18%2.70%2.62%2.41%1.33%0.67%0.58%0.16%0.17%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets179.16M331.23M470.92M621.25M1.45B3.42B4.28B4.60B3.74B3.25B3.59B3.58B3.49B3.71B3.65B
Total Liabilities68.32M128.66M162.59M206.12M159.36M1.59B1.99B2.33B2.35B1.57B1.20B1.06B782.49M771.65M706.06M
Total Equity110.84M202.58M306.13M413.83M1.29B1.62B1.89B1.87B1.34B1.64B2.35B2.51B2.71B2.94B2.95B
Cash34.85M58.80M93.44M108.68M488.28M315.15M378.84M417.29M436.59M328.21M666.31M806.41M958.88M728.64M657.57M
Total Debt30.00M67.00M78.00M100.77M-464.00M1.20B1.57B1.50B926.66M481.87M331.64M73.65M67.13M-
Net Debt-4.85M8.20M-15.44M-7.91M-488.28M148.85M819.98M1.16B1.07B598.45M-184.44M-474.77M-850.71M-661.50M-

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow49.82M46.78M100.06M116.51M177.55M2.45M-128.40M418.80M601.17M912.07M515.48M564.67M633.53M397.81M266.61M
Investing Cash Flow-63.09M-56.41M-72.01M-91.37M-406.94M-717.87M-392.95M-451.14M-288.55M-253.02M-187.56M-232.49M-200.78M-527.11M-
Financing Cash Flow33.11M32.45M7.21M-14.20M612.41M472.48M652.90M66.67M-290.75M-774.26M24.20M-221.07M-294.38M-96.42M-
Capital Expenditure30.71M56.60M72.61M73.63M92.27M292.59M412.19M446.22M363.20M383.43M201.82M303.13M280.37M420.54M191.41M
Free Cash Flow19.11M-9.82M27.46M42.88M85.27M-290.14M-540.59M-27.41M237.97M528.64M313.67M261.53M353.16M-22.73M75.21M
Dividends Paid3.51M3.81M4.48M35.77M2.55M45.33M49.23M116.40M50.21M125.37M60.02M36.38M49.88M52.47M51.99M
FCF to OCF38.36%-21.00%27.44%36.80%48.03%-11824.42%421.03%-6.55%39.58%57.96%60.85%46.32%55.75%-5.71%28.21%
Dividend Paid to FCF18.38%-38.77%16.30%83.44%2.99%-15.62%-9.11%-424.59%21.10%23.72%19.14%13.91%14.12%-230.90%69.13%

Earnings

Report DateAug 20, 2015Oct 23, 2015Dec 31, 2015Apr 27, 2016Aug 26, 2016Oct 27, 2016Apr 25, 2017Aug 28, 2017Oct 29, 2017Apr 19, 2018Aug 20, 2018Oct 26, 2018Mar 19, 2019Apr 29, 2019Aug 17, 2019Oct 29, 2019Apr 28, 2020Aug 28, 2020Oct 30, 2020Apr 27, 2021Aug 27, 2021Oct 29, 2021Apr 28, 2022Aug 26, 2022Oct 26, 2022Apr 28, 2023Aug 19, 2023Oct 26, 2023May 24, 2024Aug 29, 2024Oct 26, 2024May 23, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------
EPS Actual0.100.140.140.110.140.170.100.140.190.190.180.200.120.210.160.220.480.170.210.210.150.100.180.200.150.190.270.140.210.260.120.080.070.010.010.090.07
Surprise-------------------------------------
TimingAfter-hoursPre-market-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-market---------Pre-market-----After-hours--After-hours-----

Key Statistics & Ratios

Market Cap3.93B
Enterprise Value2.91B
Trailing P/E60.29
Forward P/E0.00
Price / Sales2.41
Price / Book1.29
EPS0.17
Book Value7.82
Revenue (TTM)1.63B
Gross Profit (TTM)540.59M
EBITDA144.17M
Profit Margin4.19%
Operating Margin0.76%
Return on Equity2.27%
Return on Assets-0.10%
Shares Outstanding383.84M
Shares Float202.63M
Beta0.32
Dividend Yield0.32%
Dividend Rate0.03
Payout Ratio18.54%

Dividends

20261×
0.03Jun 11, 2026
20251×
0.13Jun 23, 2025
20241×
0.13Jun 7, 2024
20231×
0.10Jun 16, 2023
20221×
0.10Jun 8, 2022
20211×
0.16Jul 5, 2021
20191×
0.15Jun 6, 2019
20181×
0.13Jun 29, 2018
20171×
0.06Jun 20, 2017
20161×
0.10Jun 21, 2016

Stock Splits

  • Sep 17, 201530:10